5'-O-trityl-3'-O-mesyl-2'-deoxy-5-fluorouridine | 101039-89-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 三苯基化合物
• 英文名称: 5'-O-trityl-3'-O-mesyl-2'-deoxy-5-fluorouridine
• 英文别名: 3'-O-mesyl-5'-O-trityl-5-fluoro-2'-deoxyuridine；(2R,3S,5R)-5-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-((trityloxy)methyl)tetrahydrofuran-3-yl methanesulfonate；1-(2-deoxy-3-O-methanesulfonyl-5-O-trityl-β-D-ribopentofuranosyl)-5-fluorouracil；5-fluoro-3'-O-(methylsulfonyl)-5'-O-trityl-2'-deoxyuridine；[(2R,3S,5R)-5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-2-(trityloxymethyl)oxolan-3-yl] methanesulfonate
• CAS: 101039-89-8
• 化学式: C₂₉H₂₇FN₂O₇S
• 分子量: 566.607
• InChiKey: CAFAOSDAPZXKAC-JIMJEQGWSA-N

物化性质

• 熔点：
  96-98 °C
• 密度：
  1.43±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  40
• 可旋转键数：
  9
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  120
• 氢给体数：
  1
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  5'-O-trityl-3'-O-mesyl-2'-deoxy-5-fluorouridine 在 palladium on activated charcoal 叠氮化锂 、 对甲苯磺酸 、 溶剂黄146 作用下， 以 六甲基磷酰三胺 、 乙醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 100.0 ℃ 、275.79 kPa 条件下， 反应 10.83h， 生成 3'-amino-2',3'-dideoxy-5-fluorouridine
  参考文献：
  名称：

  Colla; Herdewijn; De Clercq, European Journal of Medicinal Chemistry, 1985, vol. 20, # 4, p. 295 - 301

  摘要：

  DOI：
• 作为产物：
  描述：

  甲基磺酰氯 、 5-氟-1-[4-羟基-5-[三(苯基)甲氧基甲基]四氢呋喃-2-基]嘧啶-2,4-二酮 以 吡啶 为溶剂， 生成 5'-O-trityl-3'-O-mesyl-2'-deoxy-5-fluorouridine
  参考文献：
  名称：

  各种1-（2'-脱氧-β-d-呋喃糖基），1-（2'-氟-β-d-木呋喃糖基），1-（3'-氟-β-d-阿拉伯呋喃糖基）和2'-Fluoro-2'，3'-didehydro-2'，3'-dideoxyribose嘧啶核苷类似物抗鸭乙型肝炎病毒（DHBV）和人乙型肝炎病毒（HBV）复制

  摘要：

  尽管存在成功的疫苗和抗病毒疗法，但乙型肝炎病毒（HBV）的感染仍然是急性和慢性肝病以及高死亡率的全球主要原因。我们合成并评估了几种lyxofuranosyl，2'-fluorooxylofuranosyl，3'-fluoroarabinofuranosyl和2'-fluoro-2'，3'-didehydro-2'，3'-dideoxyribose嘧啶核苷类似物对乙型肝炎病毒的抗病毒活性。在所检查的化合物中，1-（2-脱氧-β - d-呋喃呋喃糖基）胸腺嘧啶（23），1-（2-脱氧-β - d-呋喃呋喃糖基）-5-三氟甲基尿嘧啶（25），1-（2-脱氧-2-氟-β - d-木呋喃糖基）尿嘧啶（38），1-（2-脱氧-2-氟-β- d-二呋喃呋喃糖基）胸腺嘧啶（39），2'，3'-二脱氧-2'，3'-二脱氢-2'-氟胸苷（48）和2'，3'-二脱氧-2'，3'-二脱氢-2在原代鸭肝细胞中发现'

  DOI：

  10.1021/jm100803c

文献信息

• Nucleoside dimers analogues with a 1,2,3-triazole linkage: conjugation of floxuridine and thymidine provides novel tools for cancer treatment. Part II
  作者：Dagmara Baraniak、Daniel Baranowski、Piotr Ruszkowski、Jerzy Boryski

  DOI：10.1080/15257770.2019.1610891

  日期：2019.11.2

  Abstract The fluorinated nucleoside dimers with a 1,2,3-triazole linkage are novel compounds within the field of bioorganic chemistry. We report on the synthesis and properties of two groups of nucleoside dimers analogs possessing a different arrangement of the 1,4-disubstituted 1,2,3-triazole linkage. Based on analysis of the 3JHH, 3JH1′C2, and 3JH1′C6 we estimated conformational preferences of sugar

  摘要具有1,2,3-三唑键的氟化核苷二聚体是生物有机化学领域中的新型化合物。我们报告了具有1,4-二取代的1,2,3-三唑键的不同排列的两组核苷二聚体类似物的合成和性质。基于对3JHH，3JH1'C2和3JH1'C6的分析，我们估计了糖部分的构象偏爱和糖苷键周围的方向。这些化合物显示出中等的抗癌活性，并在三种不同的癌细胞系中进行了细胞抑制研究。
• 3′-Bromo Analogues of Pyrimidine Nucleosides as a New Class of Potent Inhibitors of<i>Mycobacterium tuberculosis</i>
  作者：Neeraj Shakya、Naveen C. Srivastav、Nancy Desroches、Babita Agrawal、Dennis Y. Kunimoto、Rakesh Kumar

  DOI：10.1021/jm100165w

  日期：2010.5.27

  Tuberculosis (TB) is a major health problem worldwide. We herein report a new class of pyrimidine nucleosides as potent inhibitors of Mycobacterium tuberculosis (M. tuberculosis). Various 2'- or 3'-halogeno derivatives of pyrimidine nucleosides containing uracil, 5-fluorouracil, and thymine bases were synthesized and evaluated for antimycobacterial activities. Among the compounds tested, 3'-bromo-3'-deoxy-arabinofuranosylthymine (3') was the most effective antituberculosis agent in the in vitro assays against wild-type M. tuberculosis strain (H37Ra) (MIC50 = 1 mu g/mL) as well as drug-resistant (H37Rv) (rifampicin-resistant and isoniazid-resistant) strains of M. tuberculosis (MIC50 = 1-2 mu g/mL). Compound 3' also inhibited intracellular M. tuberculosis in a human monocytic cell line infected with H37Ra, demonstrating higher activity against intramacrophagic mycobacteria (80% reduction at 10 mu g/mL concentration) than extracellular mycobacteria (75% reduction at 10 mu g/mL concentration). In contrast, pyrimidine nucleosides possessing 5-fluorouracil base were weak inhibitors of M. tuberculosis. No cytotoxicity was found up to the highest concentration of compounds tested (CC50 > 100-200 mu g/mL) against a human cell line. Overall, these encouraging results substantiate the potential of this new class of compounds as promising antituberculosis agents.
• HALO-DEHYDRO-3'-DEOXYURACIL PHOSPHORAMIDATES AND RELATED COMPOUNDS AND THEIR USE IN TREATING MEDICAL CONDITIONS
  申请人：[en]ROME THERAPEUTICS, INC.

  公开号：WO2024107850A1

  公开（公告）日：2024-05-23

  Substituted halo-dehydro-3'-deoxyuracil phosphoramidates and related compounds, pharmaceutical compositions, their use for inhibiting LINE1 reverse transcriptase and/or HERV-K reverse transcriptase activity, and their use in the treatment of medical disorders, such as cancer, are disclosed herein.